Piramal Pharma Solutions Achieves Strong Audit Performance

Piramal Pharma Solutions (PPS), a prominent global Contract Development and Manufacturing Organization (CDMO), has completed over 200 customer audits and received more than 70 regulatory approvals across its global network in the past fiscal year. This accomplishment highlights PPS’s commitment to its long-term quality strategy focused on sustained compliance, audit readiness, and operational effectiveness.

The company attributes its success to robust governance, a strong quality culture, workforce development, and digital transformation efforts. Central to this strategy is a comprehensive quality governance framework, predictive quality tools for assessing site readiness and tailored systems to enhance efficiency while minimizing errors. Initiatives like the RESOLVE program aim to ensure precision in manufacturing and QC laboratories.

Digitalization further supports quality processes at PPS. The eLab and exForms platforms enhance laboratory operations and compliance, while the AI-enabled iAssist tool aids in speeding up investigations. These efforts have resulted in greater efficiency and transparency in operations.